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Abstract. Liver tissue grafts between seven H - 2  mutants and their parental 
strains have been studied. Each of these mutants was originally identified by 
reciprocal m u t a n t - p a r e n t a l  strain skin graft rejection. However, liver grafts 
among mutants and parental standard strains are not uniformly rejected. Liver 
graft rejection also fails to correlate with mutant -pa ren t a l  stimulation in CML 
and MLC. In addition, the immune reaction pattern of female mutant animals 
against grafts of male liver differs from the reaction pattern found in parental 
standard strains. Several explanations for the differences between immune 
response to liver and skin grafts are proposed, including different T cell subsets 
involved in recognition, availability of antigenic sites to immunocompetent cells, 
and structural differences between mutant and parental H-2 antigens. 
Introduction 
Twenty-seven H - 2  mutants have been identified by one or another of three 
laboratories (Nairn et al. 1980). The inbred lines that developed from these mutants 
have further facilitated genetic analyses of the H - 2  complex, as well as the 
assignment of immunological reactivities to its regions. These mutants were 
identified by unexpected skin graft rejection when mice were screened by the skin 
graft method of Bailey and Usama (1960) or some modification thereof. In addition 
to skin graft reactivity, mutant strains exhibit histogenic differences from their 
parental strains as detected by a variety of tests (reviewed by Klein 1978, Kohn et al. 
1978, Egorov 1974, Ben-Nun et al. 1980, Egorov et al. 1979, McKenzie et al. 1979, 
Wu et al. 1980, Streitein and Klein 1980, Bennett et al. 1980, Melief et al. 1980, Davis 
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Abbreviations used in this paper: bml, 2, 3, 4, 14; dml; fm2 = mutants of strains C57BL/6, B10.D2 and 
B10.M respectively; B6=C57BL/6 
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et al. 1980). These tests, which include cell mediated lymphocytotoxic i ty  (CML), 
mixed lymphocyte  culture (MLC), graft vs. host  reactivity (GVHR), susceptibility to 
au to immune  thyroiditis, T-cell function, hybrid resistance, tolerance induct ion and 
heart  graft rejection, do not  all show equivalent mutant-parenta l  strain differences. 
Serological differences between parents and mutants  have been difficult to 
demonst ra te  in most  cases. 
Recently the class 1 molecules of several of these mutants  (Brown and 
Na thenson  1977, Brown et al. 1978, Ewenstein et al. 1980, and Nisizawa et al. 1981) 
have been subjected to structural  analyses. These studies have shown mutant -  
parental  differences in the amino acid sequences of the H-2K,  D and/or  L structural 
proteins varying from one to several amino acids (reviewed by Nai rn  et al. 1980). We 
have studied seven H-2 mutan t  strains in the liver slice to kidney bed grafting system 
(Schultz et al. 1976). These mutants  differ f rom their s tandard strains of origin as 
demonst ra ted  by the ability to acutely reject skin grafts and by their vigorous C M L  
and M L C  reactivity. However,  serological reactivity and quantitative reactions in 
C M L  and M L C  are not  identical in all s tandard  strain-mutant,  and mutan t -mutan t  
combinations.  The published values for these immunological  parameters  are 
summarized in Table 1. We have previously demonst ra ted  (Schultz et al. 1976, 
Schultz et al. 1978) that  genetic control  of liver to kidney bed graft survival in inbred 
strains and congenic lines is not  identical to the control  of skin graft survival. It is, 
therefore, of interest to determine whether liver graft survival among  mutants  and 
between mutan t  and s tandard  strains is in agreement with skin graft survival data. 
We are also interested in the predictive value of in vitro cellular immune assays such 
as the C M L  and M L C  and serological typing for liver graft survival. The correlat ion 
of changes in the biochemical  structure of the H-2K,  H-2D,  and/or  H-2L gene 
products  with the observed survival of either skin or liver to kidney grafts is also of 
importance.  The results of the following studies have supplied answers to some of 
these questions. 
Materials and Methods 
Mutant and parental strains were obtained from the following sources: B6.C-H-2 bin1 (bin1), B6-H-2 b'3 
(bin3), and B 10.D2-H-2 d'~l (din1) were bred in our laboratory from breeders originally supplied by Dr. Jan 
Klein of the Max Planck Institute, Ttibingen, Federal Republic of Germany. Breeders for the remaining 
mutant strains [B6.C-H-2 bin2 (bin2), B6.C-H-2 b"4 (bin4), B6 C-H-2 b''14 (bin14), and B10.M-H-2 I~2 (fm2)] 
were obtained from Dr. Donald Bailey of The Jackson Laboratory. The strains B10.M and B 10.D2 were 
bred in our animal colony at the VA Medical Center in Ann Arbor, Michigan. Strains C57BL/10 (B 10), 
B10.D2, and C57BL/6 (B6) were obtained from The Jackson Laboratory and the National Cancer 
Institute. 
The liver-to-kidney bed grafting system employed has been described in detail previously (Schultz et 
al. 1976). In brief, a small piece of liver taken from an anesthesized donor is placed on the etherized 
recipient's left kidney, which has been prepared by removing a shallow subcapsular slice. The recipient's 
abdominal incision is sutured and the mouse returned to the animal colony. At predetermined times, the 
recipient mice are killed by cervical dislocation. Grafted kidneys are removed, fixed, trimmed, embedded, 
sectioned, and stained. Numerous sections of each grafted kidney are screened to locate the central area 
of the graft. Three slides containing sections from the most central areas of the graft are then evaluated. 
Histological scores are based on a previously reported evaluation system (Schultz et al. 1978). This 
system uses "P" to identify a proliferating graft with more than four layers of hepatocytes with or without 
cellular immunological activity, "S" to identify a syngeneic-like graft with 34  well organized layers of 
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Donor or Recipient or Mean Survival Serological LI CML Activity Heart 
stimulator responder Time (MST) of differences index graft 
locus of locus of skin grafts (days) MLC rejection 
mutation mutation (%) 
Source ~ 
bml(H-2K) B6 16.5 _+* + 5.9 NT 
B6 bml(H-2K) 15.1 + + 5.8 58(6weeks) ¶ 
bm2(H-2K) B6 + $ NT NT NT NT 
B6 bm2(H-2K) + NT NT NT NT 
bm3(H-2K) B6 21.8 +,  _+ t + 7.7 70 (6 weeks) [] 
B6 bm3(H-2K) 18.5 +,  ± + 8.7 50(4 weeks) [] 
bm4(H-2K) B6 + + + + NT 
B6 bm4(H-2K) + + + + NT 
bm14(H-2D) B6 + NT + NT NT 
B6 bm14(H-2D) + NT + NT NT 
dml(H-2D, H-2L) B10.D2 16.2 + + 2.5 80(5 weeks) O 
B10.D2 dml(H-2K, H-2L) 17.0 + + 9.2 70(4weeks) O 
fm2(H-2D) B10.M + + + + NT 
B10.M fin2(H-2D) + + + + NT 
brn1(H-2K) brn3(H-2K) 14.0 +, ,+ + NT NT A 
bm3(H-2K) bml(H-2K) 15.0 +,  _+ + NT NT 
* _+ = quantitative difference only 
t +,  _+ = only one weak antigenic difference and quantitative difference 
$ + = rejected- M.S.T. not available 
II by cytotoxic test using antisera against standard H-2 specific±ties- bml and bm4 grafts fail to elicit antibodies in 
parental strain nor do parental strain grafts elicit antibodies in bml and bm4-dml grafts elicit antibodies in 
B10.D2. The reciprocal is also true. 
General sources: Klein 1978 and Kohn et al. 1978 
¶ Davis et al. 1980 
© Egorov 1974 
ZSApt et al. 1975, Melief et al. 1980 
[] Klein 1976 
hepatocytes with little or no cellular immunological activity, "C-I" to identify a healthy graft with a few 
lymphocytes concentrated or in small nodules at the graft-bed interface, "C-2" to identify a graft 
containing less healthy, poorly organized hepatocytes with a considerable number of lymphocytes 
scattered throughout the graft, "C-Y' to identify a graft containing degenerating scattered hepatocytes, 
copious lymphocytic infiltrate and fibrovascular tissue, "C-4" to identify a graft with lymphocytes 
present in large nodules and with only a few scattered hepatocytes in a young scar, "C-5" to identify a 
graft consisting of fibrovascular tissue with some collagen (young scar), a few lymphocytes present and no 
hepatocytes in evidence, and "C-6" to identify a graft with only a matured (contracted) scar from which 
most lymphocytes have receded. The appearance of a graft identified as "C-6" is indistinguishable fiom 
the appearance of an acutely rejected graft such as seen across an H-2 barrier (DeMott-Friberg et al. 
1979). 
R e s u l t s  
O u r  resu l t s  for  l iver graf t  to  k i d n e y  b e d  survival ,  s u m m a r i z e d  in F i g u r e  1, s h o w  
c o n t r o l  s y n g e n e i c  m a l e  to  m a l e  l iver graf t s  su rv iv ing  at  70 d af ter  g ra f t ing  in t h r e e  H -  
2 b m u t a n t  s t r a in s  (bin1, bm3, bin14). M a l e  to  m a l e  graf t s  in the  dml s t ra in ,  a l t h o u g h  
u n i f o r m l y  surv iv ing ,  c o n t a i n  s o m e  i m m u n o l o g i c a l l y  c o m p e t e n t  cells. 
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Male to female grafts in mutant strains bin1 and bm3 are rejected by bmi females 
56 d after grafting and by bin3 females 70 d after grafting. Male to female grafts in 
bin14 and dml survive at 70d after grafting although immunological activity is 
clearly present in the grafts. Some male to female grafts in the B6 standard strain 
survive at 105 d after grafting; all grafts are not rejected until 140 d after grafting. 
Reciprocal grafts between mutant and standard strains show a variable survival 
pattern. Some grafts from B6 males to bin1 males, B6 to bin3 males and bm3 males to 
B6 males are in chronic immunologic difficulty but few are rejected by 70 d after 
grafting. However, bin1 to B6 and bin4 to B6 male to male liver grafts are uniformly 
rejected by 70 d. Only one of seven bin2 to B6 grafts is surviving at 70 d. Grafts from 
the H-2D b mutant, bin14, to its standard parental, B6, and the reciprocal of these 
grafts survive with only very minor immunological activity. 
Reciprocal grafts differ radically in the dml to B10.D2 combination. While all 
din1 to B10.D2 grafts are rejected by 35 d after grafting, B10.D2 to dml grafts still 
survive at 140 d after grafting. Grafts survive in thefm2 to B10.M combination and 
its reciprocal. 
A variety of reactions occur in grafts among mutant strains and these, too, differ 
in reciprocal combinations. Grafts from bm14 males to bin1 males survive with some 
immunologic activity at 70 d after grafting, while bin1 to bml4 grafts are rejected 
completely in seven of eight animals sampled at 70d. There is moderate 
immunological activity in bml4 to bin3 grafts at 70 d after grafting. The reciprocal 
combination is also in immunologic difficulty, but grafts survive in all but one 
animal. Only five of 18 grafts between bin1 and bm3 animals survive at 70 d after 
grafting. 
Increasing 
Donor Recipient Time Immunological Activity No. In 
'- Group 
P $ / 2 3 4 .5,6 
bmld bmlO' 70 -4-- -  6 
bml(f bml 9 56 I 6 
bm3o" b m 3 d  70  - -  t 8 
bm3~ bm39 35 -mr 5 
70 I 8 
bml4( f  bm l4d  70 I 8 
bml4 o" bml4g 70  I 9 
druid" dmld 70 - f ~  5 
dmlo" drnl£ 70  6 
bml{f B60'  70 I 9 
B60" brnld 70 I 8 
bm3(f B6d  70 9 
B6g bm3d 70 I 8 
bm2(f B6d  70  7 
bm4rt B60' 70  I 8 
bml4d B6d  70 I I0 
B 6 d  bml4o" 70  I 7 
dmld' BlO.D2d 3 5 - 7 0  I 12 
B lO.D2d dml( f  140 I II 
fm2d BIO. MO" 70  I - 8 
BIO. Md fm2d' 70 I 9 
B 6 d  B6~ 70 I 7 
105 I 7 
14-0 I 8 
B6d  B 6 d  70  4 
BIO-D2d" BIO.D2£ 70 4- 
brnlo" bm3d 70 I 6 
brn3O' braid 70 - -  12 
brnl4d' bmld 70 [ 8 
braid' bml4d 70 I 8 
bml4d bm3d 70 I 9 
bm3d' bml4d 70 5 
Fig. 1. Liver graft rejection grades. 
Horizontal lines indicate range of im- 
munological activity from P to C5, 6. 
Vertical lines indicate the mean level of 
immunological activity. 
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Discussion 
Although all the mutants included in this study were originally identified by their 
ability to acutely reject skin grafts from their standard strains of origin (see Table 1), 
different results are obtained with liver tissue to kidney bed grafts. Skin grafts are 
rejected more easily than liver grafts (Table 1 and Fig. 1). One possible reason for 
this difference between skin graft and liver graft survival in mutants is the region in 
which the mutation is located. All of the H-2 b mutants studied are H-2K region 
mutations except for bml4 which has been assigned to the H-2D region. 
Immunological activity in liver grafts in the bml4 to B6 mutant-parental strain 
combination is extremely low compared with activity in bm4 to B6 and bml to B6 
combinations. However, bin3 to B6 grafts survive at 70 d after grafting. Therefore, 
H-2 regional locale of mutations does not entirely explain the difference in behavior 
of skin and liver grafts in H-2 b mutants. 
Biochemical analysis has revealed that the bin3 mutant has amino acid 
alterations at positions 77 and 89 in CNBr fragment Ib of the H-2K b peptide 
(Ewenstein et al. 1980). Two amino acid residues, 155 and 156 in CNBr fragment Ia 
of the H-2K b peptide, are altered in the bml mutant. Mutant bin4 also has an altered 
Ia CNBr fragment (cited in Nairn et al. 1980). 
Mutants bml and bin4 perform similarly in the liver graft system, in that grafts 
from them to the B6 standard strain are rejected by 70 d after grafting. Grafts from 
the bin3 mutant to the B6 standard strain are not rejected at this time. These results 
are consistent with the hypothesis that changes in the CNBr Ia fragment cause 
structural alterations in the histocompatibility antigens, which evoke a strong 
immunological response in the B6 standard strain. Changes that occur in the bm3-Ib 
CNBr fragment alter the structure of the histocompatibility antigens to a lesser 
extent and, therefore, evoke a poorer response in B6. 
Some liver to kidney grafts from bml to bin3 and bin3 to bml survive at 70 d after 
grafting in spite of the structural differences in these mutants. These structural 
differences do cause acute rejection of skin grafts between these strains (Table 1). 
It is generally accepted that MLC and CML are tests of cellular immune activity. 
Cellular immune activity is also the maj or potentiator of graft rejection. Therefore, a 
higher MLC stimulation index would be expected in donor-recipient combinations 
in which grafts are rejected. Rejection of grafts would also be expected when positive 
CML occurs. CML is positive in all combinations that we have tested (Table 1) but 
liver to kidney graft results vary. Although bm3-B6 grafts survive longer than bml- 
B6 grafts, MLC stimulation index is higher in bm3-B6 combinations then in bml-B6 
combinations (Table 1). CML and MLC among H-2 b mutants and their parentals 
do not correlate with liver tissue graft results. 
Male to female liver tissue grafts are rejected in the bml (H-2K b) mutant by 56 d 
after grafting and in the bin3 (H-2K b) mutant by 70d after grafting. In the B6 
parentals, some male to female grafts still survive at 105 d (Fig. 1). The mutational 
events in bml and bm3 appear to have altered either the immune response of the 
female to antigenic sites on male liver or the manner of presentation of those sites to 
the female immune system. 
Mutant strains dml and bml4 are both H-2D mutants. The H-2 ~ mutant, dmI, is 
similar to the H-2 b mutant, bml4, in that parental to mutant liver grafts are viable 
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at 70d after grafting and as long as 140d in the case of B10.D2 to din1. However, the 
reciprocal combination in the H-2 d mutant (dml to B10.D2) is rejected by 35 d after 
grafting. This result would indicate a gain in an antigenic site or sites in the dml 
mutant critical in the liver grafting system. A reciprocal difference is noted between 
dml and B10.D2 in MLC depending on which strain is employed as stimulator and 
which is employed as responder. B10.D2 stimulates din1 considerably more than 
din1 stimulates B10.D2 (Table 1). Since the opposite liver graft results from those 
observed would be predicted from MLC data, it would appear that liver graft 
reactions cannot be predicted by MLC results in this mutant-parental combination. 
We previously reported (Schultz et al. 1977, 1981) that it is the K rather than the 
D region of the MHC that has major control over liver graft survival. The minor 
effect on this grafting system of the mutational changes in thefm2 and bin14 (H-2D) 
mutants as compared with effects of the mutations in bin1, bin3, and bin4 (H-2K) 
mutants support these findings (See Fig. 1). 
Both bml and bm3 grafts elicit greater immune response in bml4 animals than 
do bml4 grafts in bin1 and bin3 mice. Thus bin14 behaves much like the B6 parental 
strain in the liver graft system; further evidence that changes in the H-2D b region fail 
to affect liver graft survival in the same way as they effect skin graft survival. 
However, the din1 to B10.D2 graft results argue for the importance of the D end 
of the MHC in control of liver tissue graft survival, since these grafts are rejected as 
early as 35 d after grafting. Approximately 30~o (6-7) of the peptides of the H-2D d 
molecule have been altered in the din1 mutant (Brown et al. 1978, Nairn 1980). In 
addition, there are changes in the carbohydrate side chains of the H-2D am1 
molecule. The H-2L region of this mutant has also been altered (Bennett et al. 1980, 
Wilson et al. 1982). Antigens are present in dml that are absent in B10.D2 and the 
possibility exists that D dml is a hybrid molecule. The din1 mutant phenotype, 
therefore, is unexpectedly complex and very different from the B10.D2 phenotype. 
The extent of the biochemical changes in this mutant and/or the regions covered by 
these changes (H-2D and H-2L) may explain the vigorous rejection of dml liver 
grafts by B10.D2. It must be noted, however, that, although these large differences 
exist between the structures of the H-2DdL d and the H-2DdmlL am1 molecules, liver 
grafts from B10.D2 to din1 survive as long as 140d after grafting. The immune 
response of females to grafts of male liver is not altered by these mutational changes 
since din1 male to female liver grafts do not differ in survival pattern from B10.D2 
male to female grafts. 
In summary, our data show that skin graft, CML, MLC, and serological 
reactivity cannot be used to predict rejection or survival of liver tissue. We can 
tentatively report that differences in the biochemical structure of H-2 antigens 
correlate with liver tissue graft behavior. Alterations in the H-2D region have a 
limited effect on liver graft survival as compared with changes in the H-2K or H-2D 
plus H-2L regions. Moreover, it appears that alterations in different peptide 
fragments of the H-2K b antigen may differentially effect the ability of a liver graft to 
elicit an immune response. Several explanations are possible for the differences 
noted in liver and skin graft survival in H-2 mutant strains. It is most likely that 
different T-cell subsets are involved in these two responses. T cells that are 
responsible for liver tissue rejection may carry different receptors from T cells 
responsible for skin graft rejection. Additionally, these receptors may look at 
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different sites on the H-2 molecule or the H-2 molecule may be presented differently 
on liver cells than on skin cells. Further studies will be necessary to enable us to 
establish the exact biological events which underlie differences in the host response 
to grafts of these two tissues. 
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